MyFinsight
Home
Blog
About
Comprehensive loss
-$1,069,888
(-35.35%↓ Y/Y)
Translation adjustment
$422
(101.17%↑ Y/Y)
Technology Fees
$4,166,401
(23.58%↑ Y/Y)
Device Sales
$110,555
(-78.00%↓ Y/Y)
Net loss
attributable to common...
-$1,070,310
(-41.90%↓ Y/Y)
Revenue
$4,276,956
(10.40%↑ Y/Y)
Net loss before
dividends
-$959,468
(-42.78%↓ Y/Y)
Preferred stock dividends
$110,842
(34.65%↑ Y/Y)
Gross profit
$3,530,820
(13.28%↑ Y/Y)
Cost of revenue
$746,136
(-1.46%↓ Y/Y)
Net loss before
income taxes
-$959,468
(-42.78%↓ Y/Y)
Income (loss) from
operations
$158,068
(-43.94%↓ Y/Y)
Other
income/(expense) note 3
$40,904
(-38.65%↓ Y/Y)
Total operating
expenses
$3,372,752
(18.97%↑ Y/Y)
Interest expense
$851,753
(0.18%↑ Y/Y)
Accretion and
amortization expenses
-$196,636
(-28.04%↓ Y/Y)
Change in fair value of
derivative liabilities...
-$110,051
(-336.71%↓ Y/Y)
Selling, general and
administrative expenses
$2,699,308
(26.21%↑ Y/Y)
Research and development
expenses
$673,444
(-3.26%↓ Y/Y)
Back
Back
Income Statement
BIOTRICITY INC. (BTCY)
BIOTRICITY INC. (BTCY)
source: myfinsight.com